Princeton, New Jersey, April 25, 2012 – Sandoz today announced the introduction of enoxaparin sodium injection, USP 3 mL vials, a generic version of Sanofi's Lovenox® Injection Multiple-Dose Vials, in ...
July 26, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ...
Combating patient noncompliance with DVT prophylaxis Successful DVT prophylaxis with pharmacologic agents and adjunctive treatment modalities depends on both consistency and accuracy. Before deciding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results